Sermorelin starts working on the first night. IGF-1 is measurably elevated within 2 weeks. The gap between when it starts working biochemically and when you notice anything is the single most common reason people quit a protocol that was succeeding.
Sermorelin begins stimulating GH release from the first correctly timed dose. What takes time is the accumulation of downstream effects. IGF-1 rises measurably within 2 weeks [1], sleep changes are usually noticed between weeks 2 and 4, and body composition responds over 3 to 6 months. Anyone judging the protocol before that last window is measuring it against a timeline no published study supports.
- Biochemical response begins immediately; IGF-1 is measurable within 2 weeks [1]
- Sleep depth is the first change most people notice, at 2 to 4 weeks
- The 90-day IGF-1 retest is the real decision point
- Visceral fat reduction in GHRH-analog data took roughly 6 months [2]
- Fat mass had not changed significantly at 16 weeks in the controlled trial [1]
The Timeline, Stage by Stage
| When | What is happening | What you can observe |
|---|---|---|
| Night 1 | GH pulse amplitude increases during slow-wave sleep [3] | Nothing yet |
| Week 2 | [IGF-1 measurably elevated](https://pubmed.ncbi.nlm.nih.gov/9141536/) [1] | A lab draw would show it. You would not feel it |
| Weeks 2 to 4 | Sleep architecture shifts | Deeper sleep, fewer wakings, easier mornings |
| Weeks 4 to 12 | Sustained IGF-1 elevation, tissue-level effects accumulate | Recovery between training sessions improves |
| Week 12 | Response approaches peak | 90-day IGF-1 retest, the key checkpoint |
| Months 4 to 6 | Body composition responds | Waist measurement, DEXA. Scale weight is unreliable here |
| Month 6+ | Full evaluation window | Fair point to judge whether to continue |
Why Sleep Changes First
Most daily GH release occurs during slow-wave sleep [3]. Sermorelin dosed at bedtime acts directly on that pulse, so the tissue most immediately affected is the one governing the pulse itself. This is also the fastest feedback available: if sleep has not changed at all by week 4, that is worth raising with your prescriber, because it often points to a timing or technique problem rather than a dose problem.
Why 90 Days Is the Decision Point
The IGF-1 response approaches its peak around 3 months, which makes the 90-day retest the first moment you can judge the protocol on evidence rather than impression. The interpretation is straightforward.
| 90-day IGF-1 | What it means | What to do |
|---|---|---|
| Rose into mid-normal for age | Working as intended | Continue to 6 months |
| Rose slightly, still low-normal | Partial response | Discuss dose or technique with your physician |
| Unchanged | Something is wrong upstream of the dose | Review timing, food, storage, thyroid before increasing |
| Above age-adjusted range | Overshoot | Dose reduction |
A 90-day IGF-1 only tells you something if there is a pre-treatment value to compare it against. Providers that prescribe without requiring a baseline make the entire timeline unverifiable.
Body Composition Takes the Longest
This is where expectations most often break. In the 16-week controlled trial of [[Nle27]GHRH(1-29)NH2, a norleucine-substituted analog of the fragment sermorelin is built on, at 10 mcg/kg nightly](https://pubmed.ncbi.nlm.nih.gov/9141536/) [1], lean body mass rose in men, but fat mass did not change significantly across the full 16 weeks. In pooled GHRH-analog human studies, visceral fat reduction required roughly 6 months [2].
A patient at week 10 seeing no change in the mirror is seeing exactly what the trial data would predict. That is not a failing protocol, and it is the point at which most people quit.
What Makes It Faster or Slower
- Dosing at bedtime on an empty stomach. Eating first blunts the pulse through somatostatin feedback
- Consistency. Missed nights matter more than dose size within the normal range
- Sleep quality overall. The drug works with the GH pulse, so poor sleep limits the ceiling
- Thyroid status. Untreated hypothyroidism blunts the GH response independently
- Training and protein intake, which determine whether lean mass gains have anywhere to go
The response window in this guide assumes a monitored protocol run for the full course, not a short trial. Embody is our top-ranked provider at $99/month with no insurance or bloodwork required, with licensed clinicians managing dose and retest.
Frequently Asked Questions
How long does sermorelin take to work?
It begins working from the first correctly timed dose, and IGF-1 is measurably elevated within about 2 weeks [1]. Noticeable effects follow a sequence: sleep depth at 2 to 4 weeks, recovery improvements by month 2 or 3, and body composition change over 3 to 6 months. Six months is the minimum fair evaluation window.
How long until sermorelin improves sleep?
Usually 2 to 4 weeks. Sleep is typically the first noticeable change because most daily growth hormone release occurs during slow-wave sleep [3], so bedtime dosing acts directly on that pulse. If sleep has not changed at all by week 4, raise it with your prescriber, since that often signals a timing or technique problem rather than an inadequate dose.
How long before sermorelin shows physical results?
Longer than most people expect. In the 16-week controlled trial, lean body mass increased in men but fat mass did not change significantly across the whole period [1]. Pooled GHRH-analog studies found visceral fat reduction required roughly 6 months [2]. Judge body composition by waist measurement or DEXA at 6 months rather than by scale weight or photos at 8 weeks.
When should I get my IGF-1 retested on sermorelin?
At 90 days, when the response approaches its peak. That retest is the first evidence-based decision point: if IGF-1 rose into the mid-normal range for your age, continue. If it did not move, review dosing time, whether food preceded the dose, vial storage, and thyroid function before considering a dose increase. The retest only means something if a baseline was drawn first.
Is it normal to feel nothing after a month on sermorelin?
Fairly common, and not necessarily a failure. IGF-1 can be rising with no subjective change yet. Confirm you are dosing at bedtime at least 2 hours after eating, since that single variable accounts for a large share of non-response. If sleep specifically has not shifted by week 4, that is the signal worth investigating early rather than waiting for the 90-day lab.
Does sermorelin work faster at a higher dose?
Not reliably. Sermorelin acts through the pituitary, and the response is limited by somatostatin feedback, so higher doses do not scale linearly the way exogenous hormone would. The variables that most affect speed are timing relative to sleep and food, consistency, and thyroid status. Dose changes should follow the 90-day IGF-1 result rather than impatience at week 6.
References
- Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women Journal of Clinical Endocrinology & Metabolism, 1997. PMID: 9141536. https://pubmed.ncbi.nlm.nih.gov/9141536/
- Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies Growth Hormone & IGF Research, 2015. PMC4324360. https://pmc.ncbi.nlm.nih.gov/articles/PMC4324360/
- Growth hormone secretion during sleep Journal of Clinical Investigation, 1968. PMID: 5675428. https://pubmed.ncbi.nlm.nih.gov/5675428/
